From: iRDA: a new filter towards predictive, stable, and enriched candidate genes
 | mRMR | CMIM | FCBF | iRDA | ||||
---|---|---|---|---|---|---|---|---|
Error | % | # | % | # | % | # | % | # |
Multiple Myeloma (MM) | 14.45 | 7 | 14.45 | 6 | 15.03 | 10 | 16.18 | 10 |
Marfan Syndrome (MS) | 3.96 | 4 | 6.93 | 7 | 11.88 | 3 | 5.94 | 6 |
HIV Infection (HIV) | 13.86 | 8 | 11.45 | 8 | 15.06 | 7 | 10.84 | 8 |
Neurodegeneration (AD) | 0.84 | 2 | 0 | 2 | 0.84 | 2 | 0 | 2 |
avg | 8.28 | 5.25 | 8.21 | 5.75 | 10.7 | 5.5 | 8.24 | 6.5 |
AUC | % | # | % | # | % | # | % | # |
Multiple Myeloma (MM) | 90.71 | 9 | 90.09 | 9 | 91.26 | 10 | 89.84 | 9 |
Marfan Syndrome (MS) | 98.84 | 4 | 97.2 | 3 | 93.25 | 7 | 98.76 | 4 |
HIV Infection (HIV) | 91.88 | 8 | 92.42 | 8 | 87.29 | 7 | 92.49 | 8 |
Neurodegeneration (AD) | 100 | 2 | 100 | 2 | 100 | 2 | 100 | 2 |
avg | 95.36 | 5.75 | 94.93 | 5.5 | 92.95 | 6.5 | 95.27 | 5.75 |
MCC | % | # | % | # | % | # | % | # |
Multiple Myeloma (MM) | 61.52 | 7 | 63.67 | 6 | 61.55 | 10 | 59.56 | 10 |
Marfan Syndrome (MS) | 91.93 | 4 | 85.7 | 7 | 78.67 | 6 | 88.61 | 6 |
HIV Infection (HIV) | 63.06 | 8 | 68.98 | 8 | 57.99 | 7 | 70.4 | 8 |
Neurodegeneration (AD) | 98.33 | 2 | 100 | 2 | 98.33 | 2 | 100 | 2 |
avg | 78.71 | 5.25 | 79.59 | 5.75 | 74.14 | 6.25 | 79.64 | 6.5 |